Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.
Identifieur interne : 002891 ( PubMed/Corpus ); précédent : 002890; suivant : 002892Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.
Auteurs : Pramod Kumar Pal ; Talakad N. Sathyaprabha ; Prasad Tuhina ; Kandavel ThennarasuSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2007.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- complications : Parkinson Disease.
- drug therapy : Lung Diseases, Parkinson Disease.
- etiology : Lung Diseases.
- methods : Respiratory Function Tests.
- Adult, Female, Humans, Male, Middle Aged, Severity of Illness Index.
Abstract
We performed a detailed evaluation of pulmonary function in 53 patients with idiopathic Parkinson's disease (PD) who did not have symptoms of pulmonary or cardiac dysfunction. There was a significant pulmonary dysfunction of restrictive type which partially responded to levodopa. Compared to men, women were more severely affected. Pulmonary function assessment is recommended in PD, irrespective of severity of disease.
DOI: 10.1002/mds.21330
PubMed: 17230476
Links to Exploration step
pubmed:17230476Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.</title><author><name sortKey="Pal, Pramod Kumar" sort="Pal, Pramod Kumar" uniqKey="Pal P" first="Pramod Kumar" last="Pal">Pramod Kumar Pal</name><affiliation><nlm:affiliation>Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India. pal.pramod@rediffmail.com</nlm:affiliation></affiliation></author><author><name sortKey="Sathyaprabha, Talakad N" sort="Sathyaprabha, Talakad N" uniqKey="Sathyaprabha T" first="Talakad N" last="Sathyaprabha">Talakad N. Sathyaprabha</name></author><author><name sortKey="Tuhina, Prasad" sort="Tuhina, Prasad" uniqKey="Tuhina P" first="Prasad" last="Tuhina">Prasad Tuhina</name></author><author><name sortKey="Thennarasu, Kandavel" sort="Thennarasu, Kandavel" uniqKey="Thennarasu K" first="Kandavel" last="Thennarasu">Kandavel Thennarasu</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="doi">10.1002/mds.21330</idno><idno type="RBID">pubmed:17230476</idno><idno type="pmid">17230476</idno><idno type="wicri:Area/PubMed/Corpus">002891</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.</title><author><name sortKey="Pal, Pramod Kumar" sort="Pal, Pramod Kumar" uniqKey="Pal P" first="Pramod Kumar" last="Pal">Pramod Kumar Pal</name><affiliation><nlm:affiliation>Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India. pal.pramod@rediffmail.com</nlm:affiliation></affiliation></author><author><name sortKey="Sathyaprabha, Talakad N" sort="Sathyaprabha, Talakad N" uniqKey="Sathyaprabha T" first="Talakad N" last="Sathyaprabha">Talakad N. Sathyaprabha</name></author><author><name sortKey="Tuhina, Prasad" sort="Tuhina, Prasad" uniqKey="Tuhina P" first="Prasad" last="Tuhina">Prasad Tuhina</name></author><author><name sortKey="Thennarasu, Kandavel" sort="Thennarasu, Kandavel" uniqKey="Thennarasu K" first="Kandavel" last="Thennarasu">Kandavel Thennarasu</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antiparkinson Agents (therapeutic use)</term><term>Female</term><term>Humans</term><term>Levodopa (therapeutic use)</term><term>Lung Diseases (drug therapy)</term><term>Lung Diseases (etiology)</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term><term>Respiratory Function Tests (methods)</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lung Diseases</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lung Diseases</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Respiratory Function Tests</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Severity of Illness Index</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We performed a detailed evaluation of pulmonary function in 53 patients with idiopathic Parkinson's disease (PD) who did not have symptoms of pulmonary or cardiac dysfunction. There was a significant pulmonary dysfunction of restrictive type which partially responded to levodopa. Compared to men, women were more severely affected. Pulmonary function assessment is recommended in PD, irrespective of severity of disease.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">17230476</PMID><DateCreated><Year>2007</Year><Month>03</Month><Day>06</Day></DateCreated><DateCompleted><Year>2007</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2007</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.</ArticleTitle><Pagination><MedlinePgn>420-4</MedlinePgn></Pagination><Abstract><AbstractText>We performed a detailed evaluation of pulmonary function in 53 patients with idiopathic Parkinson's disease (PD) who did not have symptoms of pulmonary or cardiac dysfunction. There was a significant pulmonary dysfunction of restrictive type which partially responded to levodopa. Compared to men, women were more severely affected. Pulmonary function assessment is recommended in PD, irrespective of severity of disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pal</LastName><ForeName>Pramod Kumar</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India. pal.pramod@rediffmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathyaprabha</LastName><ForeName>Talakad N</ForeName><Initials>TN</Initials></Author><Author ValidYN="Y"><LastName>Tuhina</LastName><ForeName>Prasad</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Thennarasu</LastName><ForeName>Kandavel</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D023362">Evaluation Studies</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>46627O600J</RegistryNumber><NameOfSubstance UI="D007980">Levodopa</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008171">Lung Diseases</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName><QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D012129">Respiratory Function Tests</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>1</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>5</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>1</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1002/mds.21330</ArticleId><ArticleId IdType="pubmed">17230476</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002891 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002891 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:17230476
|texte= Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:17230476" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |